论文部分内容阅读
目的:对比分析加替沙星治疗细菌性结膜炎的疗效。方法:将在本院接受治疗的细菌性结膜炎患者68例选为本次研究的观察对象,其治疗时间均在2014年12月至2016年5月期间,采用单双号随机分组的方式将所有患者划分为2组,分别给予患者常规药物治疗(对照组)与加替沙星治疗(观察组),对两组患者的细菌清除概率、治愈耗时、治疗效果以及发生不良反应的概率进行比较。结果:观察组患者的细菌清除概率为94.12%,治愈耗时为(6.13±0.46)天,临床总有效概率为97.06%,与对照组比较,均明显较优异,P<0.05;两组患者的不良反应发生概率比较,差异不明显,P>0.05。结论:加替沙星治疗细菌性结膜炎的疗效显著,值得在今后临床中进一步推广。
Objective: To compare the efficacy of gatifloxacin in the treatment of bacterial conjunctivitis. Methods: Sixty-eight patients with bacterial conjunctivitis undergoing treatment in our hospital were selected as the observation subjects in this study. The treatment time was from December 2014 to May 2016. The patients were randomly divided into single and double groups All the patients were divided into two groups, which were given routine drug therapy (control group) and gatifloxacin treatment group (observation group) respectively. The probability of bacterial clearance, time-consuming curative effect, treatment effect and adverse reaction were compared between two groups Compare Results: The bacterial clearance rate of the observation group was 94.12%, the time of curative treatment was (6.13 ± 0.46) days, and the total clinical effective rate was 97.06%, which was significantly superior to the control group, P <0.05; The incidence of adverse reactions, the difference was not significant, P> 0.05. Conclusion: The effect of gatifloxacin in the treatment of bacterial conjunctivitis is significant and worthy of further promotion in the future.